TRCT
ARDT

Tower Research Capital (TRC)’s Ardent Health ARDT Stock Holding History

Tower Research Capital (TRC)’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Sell
1,157
-738
-39% -$7K ﹤0.01% 3951
2026
Q1 		$16.2K Sell
1,895
-2,886
-60% -$25.9K ﹤0.01% 3624
2025
Q4 		$42.2K Buy
4,781
+1,485
+45% +$17.2K ﹤0.01% 2556
2025
Q3 		$43.7K Buy
3,296
+789
+31% +$9.87K ﹤0.01% 2637
2025
Q2 		$34.2K Buy
2,507
+1,462
+140% +$19.7K ﹤0.01% 3304
2025
Q1 		$14.4K Buy
1,045
+593
+131% +$8.65K ﹤0.01% 3299
2024
Q4 		$7.72K Sell
452
-2,947
-87% -$51.1K ﹤0.01% 4053
2024
Q3 		$62.5K Buy
+3,399
New +$60.1K ﹤0.01% 2592

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tower Research Capital (TRC)'s ARDT Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Ardent Health (ARDT) stake by 39% in Q2 2026, selling an estimated $7K and leaving 1,157 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3951.

Tower Research Capital (TRC) first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $62.5K in Q3 2024. 138 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Tower Research Capital (TRC) held 1,157 shares of Ardent Health worth $11.4K as of Q2 2026.
  • Tower Research Capital (TRC) sold 738 Ardent Health shares in Q2 2026, an estimated $7K.
  • Ardent Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3951 holding.
  • Tower Research Capital (TRC) first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Ardent Health position peaked at $62.5K in Q3 2024.
  • 138 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.